A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention

Area of Science:

• Cardiology
• Interventional Cardiology
• Health Informatics

Background:

• Developing accurate risk prediction tools for outcomes after percutaneous coronary intervention (PCI) is crucial.
• Major adverse cardiac events (MACE) following PCI include mortality, revascularization, and myocardial infarction.

Purpose of the Study:

• To develop and validate a novel scoring system for predicting 1-year MACE after PCI.
• To identify key clinical, procedural, and laboratory predictors of MACE.

Main Methods:

• Data from 8206 patients undergoing PCI (2004-2009) were used to develop the score.
• A separate cohort of 2875 patients (2009-2011) served as the validation dataset.
• The score incorporated variables such as diabetes, creatinine levels, ejection fraction, acute coronary syndrome presentation, vessel disease extent, and PCI characteristics.

Main Results:

• The developed score demonstrated good predictive ability (R² = 0.795) and acceptable discrimination (c-statistic = 0.63).
• Key predictors included diabetes, elevated creatinine, reduced ejection fraction, ACS presentation, number of diseased vessels, and specific PCI details (vessel treated, stent type/diameter).
• The score effectively categorized patients into low-, moderate-, and high-risk groups for MACE, with good agreement between observed and expected risks in validation.

Conclusions:

• An individualized risk-scoring system utilizing clinical and procedural variables can reliably predict 1-year MACE post-PCI.
• This scoring system offers a practical tool for physicians to enhance decision-making and tailor post-PCI patient management.
• Accurate risk stratification facilitates personalized healthcare strategies, improving patient outcomes.